These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36634471)

  • 41. Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy.
    Barcelos LB; Saad F; Giacominelli C; Saba RA; de Carvalho Aguiar PM; Silva SMA; Borges V; Bertolucci PHF; Ferraz HB
    Clin Neurol Neurosurg; 2018 Jan; 164():121-126. PubMed ID: 29223069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Questionnaire-Based Study on Clinical REM Sleep Behavior Disorder and Subtypes in Multiple System Atrophy.
    Wu DD; Su W; Li SH; He J; Li K; Chen HB; Jin Y
    Eur Neurol; 2021; 84(5):368-374. PubMed ID: 34134116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study on the characteristics of cognitive function in patients with multiple system atrophy in China.
    Li N; Yang T; Ran W; Zhang X; Wang Y; Xu Z; Ren S; Zhao Q; Guo B; Wang S; Meng F; Chen Z
    Sci Rep; 2021 Mar; 11(1):4995. PubMed ID: 33654145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progression and prognosis in multiple system atrophy presenting with REM behavior disorder.
    Giannini G; Mastrangelo V; Provini F; Droghini A; Cecere A; Barletta G; Mignani F; Guaraldi P; Cortelli P; Calandra-Buonaura G
    Neurology; 2020 Apr; 94(17):e1828-e1834. PubMed ID: 32234825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical features and autonomic testing predict survival in multiple system atrophy.
    Coon EA; Sletten DM; Suarez MD; Mandrekar JN; Ahlskog JE; Bower JH; Matsumoto JY; Silber MH; Benarroch EE; Fealey RD; Sandroni P; Low PA; Singer W
    Brain; 2015 Dec; 138(Pt 12):3623-31. PubMed ID: 26369944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes.
    Zhang L; Cao B; Ou R; Wei QQ; Zhao B; Yang J; Wu Y; Shang H
    Parkinsonism Relat Disord; 2017 Feb; 35():63-68. PubMed ID: 27993522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions.
    Chen B; Yang W; Luo Y; Tan EK; Wang Q
    J Neurol; 2023 Nov; 270(11):5251-5273. PubMed ID: 37477834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.
    Pavy-Le Traon A; Piedvache A; Perez-Lloret S; Calandra-Buonaura G; Cochen-De Cock V; Colosimo C; Cortelli P; Debs R; Duerr S; Fanciulli A; Foubert-Samier A; Gerdelat A; Gurevich T; Krismer F; Poewe W; Tison F; Tranchant C; Wenning G; Rascol O; Meissner WG;
    J Neurol Neurosurg Psychiatry; 2016 May; 87(5):554-61. PubMed ID: 25977316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology.
    Terao Y; Fukuda H; Tokushige S; Inomata-Terada S; Yugeta A; Hamada M; Ichikawa Y; Hanajima R; Ugawa Y
    Clin Neurophysiol; 2016 Feb; 127(2):1491-1502. PubMed ID: 26350408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting the Prognosis of Multiple System Atrophy Using Cluster and Principal Component Analysis.
    Du J; Cui S; Huang P; Gao C; Zhang P; Liu J; Li H; Huang M; Shen X; Liu Z; Chen Z; Tan Y; Chen S
    J Parkinsons Dis; 2023; 13(6):937-946. PubMed ID: 37522217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic factors for inability to walk independently in patients with multiple system atrophy].
    Wang ZW; Wu XH; Qiu F; Liu JG; Yao W; Jiang M; Wang SS; Chen ZG; Qi XK
    Zhonghua Nei Ke Za Zhi; 2017 Feb; 56(2):94-98. PubMed ID: 28162177
    [No Abstract]   [Full Text] [Related]  

  • 53. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary Dysfunctions Are More Severe in the Parkinsonian Phenotype of Multiple System Atrophy.
    Yamamoto T; Asahina M; Yamanaka Y; Uchiyama T; Hirano S; Sugiyama A; Sakakibara R; Kuwabara S
    Mov Disord Clin Pract; 2016; 3(3):275-281. PubMed ID: 30363569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study.
    Yamamoto T; Sakakibara R; Uchiyama T; Liu Z; Ito T; Awa Y; Yamamoto K; Kinou M; Yamanishi T; Hattori T
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1645-8. PubMed ID: 16291887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue?
    Calandra-Buonaura G; Guaraldi P; Sambati L; Lopane G; Cecere A; Barletta G; Provini F; Contin M; Martinelli P; Cortelli P
    Neurol Sci; 2013 Oct; 34(10):1875-8. PubMed ID: 23728718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy.
    Abdo WF; van de Warrenburg BP; Kremer HP; Bloem BR; Verbeek MM
    Parkinsonism Relat Disord; 2007 Dec; 13(8):480-2. PubMed ID: 17448720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autonomic dysfunction in different subtypes of multiple system atrophy.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Berg D; Ziemssen T
    Mov Disord; 2008 Sep; 23(12):1766-72. PubMed ID: 18661564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival in synucleinopathies: A prospective cohort study.
    Goldstein DS; Holmes C; Sharabi Y; Wu T
    Neurology; 2015 Nov; 85(18):1554-61. PubMed ID: 26432848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological correlates of pyramidal signs in multiple system atrophy.
    Lin CR; Viswanathan A; Chen TX; Mitsumoto H; Vonsattel JP; Faust PL; Kuo SH
    Ann Clin Transl Neurol; 2022 Jul; 9(7):988-994. PubMed ID: 35593123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.